Independent Advisor Alliance Invests $653,000 in Invesco Nasdaq Biotechnology ETF $IBBQ

Posted by Ethan Ryder on May 17th, 2026

Independent Advisor Alliance bought a new position in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) during the 4th quarter, HoldingsChannel reports. The fund bought 22,993 shares of the company’s stock, valued at approximately $653,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. International Assets Investment Management LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at $41,000. MMA Asset Management LLC purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the third quarter valued at about $51,000. Advisory Services Network LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the third quarter valued at about $52,000. Osaic Holdings Inc. raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock valued at $101,000 after acquiring an additional 1,052 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF during the second quarter worth about $149,000.

Invesco Nasdaq Biotechnology ETF Price Performance

NASDAQ IBBQ opened at $29.00 on Friday. Invesco Nasdaq Biotechnology ETF has a 1 year low of $20.06 and a 1 year high of $30.50. The stock has a market capitalization of $65.54 million, a PE ratio of 17.03 and a beta of 0.62. The business’s 50-day moving average is $29.14 and its 200 day moving average is $28.79.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 27th. Shareholders of record on Monday, March 23rd were given a dividend of $0.0361 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Monday, March 23rd.

Invesco Nasdaq Biotechnology ETF Profile

(Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.